StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)

Close on Nov 17, 2026Market cap $37.94MP/E –Yield –

Yarrow Bioscience price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Yarrow Bioscience's price to sales ratio was 21.2× on Nov 11, 2026, against 16.0× a year earlier. Over the last 5 years it ranged from 6.7× to 102.1×, with a median of 32.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202621.2×−2.9
2025Dec 31, 202524.1×−76.1
2024Dec 31, 2024100.2×+78.5
2023Dec 29, 202321.8×+10.1
2022Dec 30, 202211.7×+0.7
2021Dec 31, 202111.0×−4.7
2020Dec 31, 202015.7×−345.5
2019Dec 31, 2019361.3×+354.1
2018Dec 31, 20187.1×–

More Yarrow Bioscience figures

See a number that looks wrong?